Selected research
Market Structure
Global Biosimilar Packaging Containers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biosimilar Packaging Containers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biosimilar Packaging Containers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biosimilar Packaging Containers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biosimilar Packaging Containers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biosimilar Packaging Containers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biosimilar Packaging Containers include West Pharmaceutical Services, Inc., Zeon Corporation, Gerresheimer, Terumo Corporation, Shandong Weigao, Schott, Sichuan Tofflon medicinal packaging materials, Wuxi Nice Life Technology and Chongzhou Junjian Plastic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biosimilar Packaging Containers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biosimilar Packaging Containers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biosimilar Packaging Containers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biosimilar Packaging Containers market size, projected growth trends, production technologies, key applications, and end-use industries.
Biosimilar Packaging Containers Segment by Company
West Pharmaceutical Services, Inc.
Zeon Corporation
Gerresheimer
Terumo Corporation
Shandong Weigao
Schott
Sichuan Tofflon medicinal packaging materials
Wuxi Nice Life Technology
Chongzhou Junjian Plastic
Plas-Tech Engineering
Merit Medical
Althena Medical
Stevanato Group
Daikyo Seiko, Ltd
Taisei Kako
Sharps Technology Inc.
Baxter Healthcare Corporation
Biosimilar Packaging Containers Segment by Type
by Type
COP Prefilled Syringe
COP Bottle
Others
Biosimilar Packaging Containers Segment by Application
by Application
Medical
Medicines
Cosmetics
Others
Biosimilar Packaging Containers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilar Packaging Containers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biosimilar Packaging Containers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilar Packaging Containers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biosimilar Packaging Containers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Packaging Containers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar Packaging Containers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biosimilar Packaging Containers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Applications
- by Application
- Medical
- Medicines
- Cosmetics
- Others
Companies covered
- West Pharmaceutical Services, Inc.
- Zeon Corporation
- Gerresheimer
- Terumo Corporation
- Shandong Weigao
- Schott
- Sichuan Tofflon medicinal packaging materials
- Wuxi Nice Life Technology
- Chongzhou Junjian Plastic
- Plas-Tech Engineering
- Merit Medical
- Althena Medical
- Stevanato Group
- Daikyo Seiko, Ltd
- Taisei Kako
- Sharps Technology Inc.
- Baxter Healthcare Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biosimilar Packaging Containers Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biosimilar Packaging Containers Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Biosimilar Packaging Containers Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Biosimilar Packaging Containers Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Biosimilar Packaging Containers Market Dynamics
- 2.1 Biosimilar Packaging Containers Industry Trends
- 2.2 Biosimilar Packaging Containers Industry Drivers
- 2.3 Biosimilar Packaging Containers Industry Opportunities and Challenges
- 2.4 Biosimilar Packaging Containers Industry Restraints
3 Biosimilar Packaging Containers Market by Manufacturers
- 3.1 Global Biosimilar Packaging Containers Revenue by Manufacturers (2021-2026)
- 3.2 Global Biosimilar Packaging Containers Sales by Manufacturers (2021-2026)
- 3.3 Global Biosimilar Packaging Containers Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Biosimilar Packaging Containers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biosimilar Packaging Containers Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biosimilar Packaging Containers Manufacturers, Product Type & Application
- 3.7 Global Biosimilar Packaging Containers Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biosimilar Packaging Containers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biosimilar Packaging Containers Players Market Share by Revenue in 2025
- 3.8.3 2025 Biosimilar Packaging Containers Tier 1, Tier 2, and Tier 3
4 Biosimilar Packaging Containers Market by Type
- 4.1 Biosimilar Packaging Containers Type Introduction
- 4.1.1 by Type
- 4.1.2 COP Prefilled Syringe
- 4.1.3 COP Bottle
- 4.1.4 Others
- 4.2 Global Biosimilar Packaging Containers Sales by Type
- 4.2.1 Global Biosimilar Packaging Containers Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biosimilar Packaging Containers Sales by Type (2021-2032)
- 4.2.3 Global Biosimilar Packaging Containers Sales Market Share by Type (2021-2032)
- 4.3 Global Biosimilar Packaging Containers Revenue by Type
- 4.3.1 Global Biosimilar Packaging Containers Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biosimilar Packaging Containers Revenue by Type (2021-2032)
- 4.3.3 Global Biosimilar Packaging Containers Revenue Market Share by Type (2021-2032)
5 Biosimilar Packaging Containers Market by Application
- 5.1 Biosimilar Packaging Containers Application Introduction
- 5.1.1 by Application
- 5.1.2 Medical
- 5.1.3 Medicines
- 5.1.4 Cosmetics
- 5.1.5 Others
- 5.2 Global Biosimilar Packaging Containers Sales by Application
- 5.2.1 Global Biosimilar Packaging Containers Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biosimilar Packaging Containers Sales by Application (2021-2032)
- 5.2.3 Global Biosimilar Packaging Containers Sales Market Share by Application (2021-2032)
- 5.3 Global Biosimilar Packaging Containers Revenue by Application
- 5.3.1 Global Biosimilar Packaging Containers Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biosimilar Packaging Containers Revenue by Application (2021-2032)
- 5.3.3 Global Biosimilar Packaging Containers Revenue Market Share by Application (2021-2032)
6 Global Biosimilar Packaging Containers Sales by Region
- 6.1 Global Biosimilar Packaging Containers Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biosimilar Packaging Containers Sales by Region (2021-2032)
- 6.2.1 Global Biosimilar Packaging Containers Sales by Region (2021-2026)
- 6.2.2 Global Biosimilar Packaging Containers Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biosimilar Packaging Containers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Biosimilar Packaging Containers Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Biosimilar Packaging Containers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Biosimilar Packaging Containers Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Biosimilar Packaging Containers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Biosimilar Packaging Containers Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Biosimilar Packaging Containers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Biosimilar Packaging Containers Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Biosimilar Packaging Containers Revenue by Region
- 7.1 Global Biosimilar Packaging Containers Revenue by Region
- 7.1.1 Global Biosimilar Packaging Containers Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Biosimilar Packaging Containers Revenue by Region (2021-2026)
- 7.1.3 Global Biosimilar Packaging Containers Revenue by Region (2027-2032)
- 7.1.4 Global Biosimilar Packaging Containers Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Biosimilar Packaging Containers Revenue (2021-2032)
- 7.2.2 North America Biosimilar Packaging Containers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Biosimilar Packaging Containers Revenue (2021-2032)
- 7.3.2 Europe Biosimilar Packaging Containers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Biosimilar Packaging Containers Revenue (2021-2032)
- 7.4.2 Asia-Pacific Biosimilar Packaging Containers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Biosimilar Packaging Containers Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Biosimilar Packaging Containers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 West Pharmaceutical Services, Inc.
- 8.1.1 West Pharmaceutical Services, Inc. Company Information
- 8.1.2 West Pharmaceutical Services, Inc. Business Overview
- 8.1.3 West Pharmaceutical Services, Inc. Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 West Pharmaceutical Services, Inc. Biosimilar Packaging Containers Product Portfolio
- 8.1.5 West Pharmaceutical Services, Inc. Recent Developments
- 8.2 Zeon Corporation
- 8.2.1 Zeon Corporation Company Information
- 8.2.2 Zeon Corporation Business Overview
- 8.2.3 Zeon Corporation Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zeon Corporation Biosimilar Packaging Containers Product Portfolio
- 8.2.5 Zeon Corporation Recent Developments
- 8.3 Gerresheimer
- 8.3.1 Gerresheimer Company Information
- 8.3.2 Gerresheimer Business Overview
- 8.3.3 Gerresheimer Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Gerresheimer Biosimilar Packaging Containers Product Portfolio
- 8.3.5 Gerresheimer Recent Developments
- 8.4 Terumo Corporation
- 8.4.1 Terumo Corporation Company Information
- 8.4.2 Terumo Corporation Business Overview
- 8.4.3 Terumo Corporation Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Terumo Corporation Biosimilar Packaging Containers Product Portfolio
- 8.4.5 Terumo Corporation Recent Developments
- 8.5 Shandong Weigao
- 8.5.1 Shandong Weigao Company Information
- 8.5.2 Shandong Weigao Business Overview
- 8.5.3 Shandong Weigao Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shandong Weigao Biosimilar Packaging Containers Product Portfolio
- 8.5.5 Shandong Weigao Recent Developments
- 8.6 Schott
- 8.6.1 Schott Company Information
- 8.6.2 Schott Business Overview
- 8.6.3 Schott Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Schott Biosimilar Packaging Containers Product Portfolio
- 8.6.5 Schott Recent Developments
- 8.7 Sichuan Tofflon medicinal packaging materials
- 8.7.1 Sichuan Tofflon medicinal packaging materials Company Information
- 8.7.2 Sichuan Tofflon medicinal packaging materials Business Overview
- 8.7.3 Sichuan Tofflon medicinal packaging materials Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sichuan Tofflon medicinal packaging materials Biosimilar Packaging Containers Product Portfolio
- 8.7.5 Sichuan Tofflon medicinal packaging materials Recent Developments
- 8.8 Wuxi Nice Life Technology
- 8.8.1 Wuxi Nice Life Technology Company Information
- 8.8.2 Wuxi Nice Life Technology Business Overview
- 8.8.3 Wuxi Nice Life Technology Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Wuxi Nice Life Technology Biosimilar Packaging Containers Product Portfolio
- 8.8.5 Wuxi Nice Life Technology Recent Developments
- 8.9 Chongzhou Junjian Plastic
- 8.9.1 Chongzhou Junjian Plastic Company Information
- 8.9.2 Chongzhou Junjian Plastic Business Overview
- 8.9.3 Chongzhou Junjian Plastic Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Chongzhou Junjian Plastic Biosimilar Packaging Containers Product Portfolio
- 8.9.5 Chongzhou Junjian Plastic Recent Developments
- 8.10 Plas-Tech Engineering
- 8.10.1 Plas-Tech Engineering Company Information
- 8.10.2 Plas-Tech Engineering Business Overview
- 8.10.3 Plas-Tech Engineering Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Plas-Tech Engineering Biosimilar Packaging Containers Product Portfolio
- 8.10.5 Plas-Tech Engineering Recent Developments
- 8.11 Merit Medical
- 8.11.1 Merit Medical Company Information
- 8.11.2 Merit Medical Business Overview
- 8.11.3 Merit Medical Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Merit Medical Biosimilar Packaging Containers Product Portfolio
- 8.11.5 Merit Medical Recent Developments
- 8.12 Althena Medical
- 8.12.1 Althena Medical Company Information
- 8.12.2 Althena Medical Business Overview
- 8.12.3 Althena Medical Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Althena Medical Biosimilar Packaging Containers Product Portfolio
- 8.12.5 Althena Medical Recent Developments
- 8.13 Stevanato Group
- 8.13.1 Stevanato Group Company Information
- 8.13.2 Stevanato Group Business Overview
- 8.13.3 Stevanato Group Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Stevanato Group Biosimilar Packaging Containers Product Portfolio
- 8.13.5 Stevanato Group Recent Developments
- 8.14 Daikyo Seiko, Ltd
- 8.14.1 Daikyo Seiko, Ltd Company Information
- 8.14.2 Daikyo Seiko, Ltd Business Overview
- 8.14.3 Daikyo Seiko, Ltd Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Daikyo Seiko, Ltd Biosimilar Packaging Containers Product Portfolio
- 8.14.5 Daikyo Seiko, Ltd Recent Developments
- 8.15 Taisei Kako
- 8.15.1 Taisei Kako Company Information
- 8.15.2 Taisei Kako Business Overview
- 8.15.3 Taisei Kako Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Taisei Kako Biosimilar Packaging Containers Product Portfolio
- 8.15.5 Taisei Kako Recent Developments
- 8.16 Sharps Technology Inc.
- 8.16.1 Sharps Technology Inc. Company Information
- 8.16.2 Sharps Technology Inc. Business Overview
- 8.16.3 Sharps Technology Inc. Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Sharps Technology Inc. Biosimilar Packaging Containers Product Portfolio
- 8.16.5 Sharps Technology Inc. Recent Developments
- 8.17 Baxter Healthcare Corporation
- 8.17.1 Baxter Healthcare Corporation Company Information
- 8.17.2 Baxter Healthcare Corporation Business Overview
- 8.17.3 Baxter Healthcare Corporation Biosimilar Packaging Containers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Baxter Healthcare Corporation Biosimilar Packaging Containers Product Portfolio
- 8.17.5 Baxter Healthcare Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biosimilar Packaging Containers Value Chain Analysis
- 9.1.1 Biosimilar Packaging Containers Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biosimilar Packaging Containers Production Mode & Process
- 9.2 Biosimilar Packaging Containers Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biosimilar Packaging Containers Distributors
- 9.2.3 Biosimilar Packaging Containers Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst